{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:10:59Z","timestamp":1768644659682,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10067-022-06066-6","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T13:04:05Z","timestamp":1642683845000},"page":"1431-1437","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring cannabis use and perspectives among psoriatic disease patients"],"prefix":"10.1007","volume":"41","author":[{"given":"Jackie","family":"Tsang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orli","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Machhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remy","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafna D.","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl F.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"6066_CR1","doi-asserted-by":"crossref","unstructured":"Ocampo DV, Gladman D (2019) Psoriatic arthritis.F1000Resarch:8","DOI":"10.12688\/f1000research.19144.1"},{"key":"6066_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman D (2017) Psoriatic arthritis. New Engl J Med 376:957\u2013970","journal-title":"New Engl J Med"},{"key":"6066_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00296-018-4201-3","volume":"39","author":"G Kilic","year":"2019","unstructured":"Kilic G, Kilic E, Nas K, Kavanaugh A, Tekeoglu I (2019) Residual sumptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required? Rheumatol Int 39:73\u201381","journal-title":"Rheumatol Int"},{"key":"6066_CR4","first-page":"891","volume":"146","author":"C Olivier","year":"2010","unstructured":"Olivier C, Robert PD, Daihung D et al (2010) The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 146:891\u2013895","journal-title":"Arch Dermatol"},{"key":"6066_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1468-3083.2011.04000.x","volume":"26","author":"TM Ljosaa","year":"2012","unstructured":"Ljosaa TM, Mork C, Stubhaug A, Moum T, Wahl AK (2012) Skin pain and skin discomfort is associated with quality of life in patients with psoriasis. J Eur Acad Dermatol Venereol 26:29\u201335","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"6066_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/ecco-jcc\/jjy185","volume":"13","author":"T Ambrose","year":"2019","unstructured":"Ambrose T, Simmons A (2019) Cannabis, cannabinoids, and the endocannabinoid system \u2013 is there therapeutic potential for inflammatory bowel disease? J Crohns Colitis 13:525\u2013535","journal-title":"J Crohns Colitis"},{"key":"6066_CR7","doi-asserted-by":"crossref","unstructured":"Wang L, Hong PJ, May C, et al. (2021) Medical Cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomized clinical trials. BMJ 373:n1034.","DOI":"10.1136\/bmj.n1034"},{"key":"6066_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2147\/JPR.S113138","volume":"9","author":"BL Wilsey","year":"2016","unstructured":"Wilsey BL, Deutsch R, Samara E et al (2016) A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. J Pain Res 9:587\u2013598","journal-title":"J Pain Res"},{"key":"6066_CR9","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1213\/ANE.0000000000002110","volume":"125","author":"H Meng","year":"2017","unstructured":"Meng H, Johnston B, Englesakis M, Moulin DE, Bhatia A (2017) Selective cannabinoids for chronic neuropathic pain: a systematic review and meta-analysis. Anesth Analg 125:1638\u20131652","journal-title":"Anesth Analg"},{"key":"6066_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jpain.2012.10.009","volume":"14","author":"B Wilsey","year":"2013","unstructured":"Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H (2013) Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain Off J Am Pain Soc 14:136\u2013148","journal-title":"J Pain Off J Am Pain Soc"},{"key":"6066_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5152\/eurjrheum.2017.17025","volume":"4","author":"N Barrie","year":"2017","unstructured":"Barrie N, Manolios N (2017) The endocannabinoid system in pain and inflammation: its relevance to rheumatic disease. Eur J Rheumatol 4:210\u2013218","journal-title":"Eur J Rheumatol"},{"key":"6066_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","volume":"79","author":"MA ElSohly","year":"2016","unstructured":"ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC (2016) Changes in cannabis potency over the last 2 decades (1995\u20132014): analysis of current data in the United States. Biol Psychiatry 79:613\u2013619","journal-title":"Biol Psychiatry"},{"key":"6066_CR13","doi-asserted-by":"crossref","unstructured":"Daniulaityte R, Nahhas RW, Wijeratne S, et al. (2015) \u201cTime for dabs\u201d: analyzing Twitter data on marijuana concentrates across the U.S. Drug Alcohol Depend 155:307\u201311.","DOI":"10.1016\/j.drugalcdep.2015.07.1199"},{"key":"6066_CR14","first-page":"1","volume":"58","author":"T Leggett","year":"2006","unstructured":"Leggett T (2006) United Nations Office on Drugs and Crime. A review of the world cannabis situation. Bull Narc 58:1\u2013155","journal-title":"Bull Narc"},{"key":"6066_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugalcdep.2011.06.011","volume":"120","author":"M Cerd\u00e1","year":"2012","unstructured":"Cerd\u00e1 M, Wall M, Keyes KM, Galea S, Hasin D (2012) Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend 120:22\u201327","journal-title":"Drug Alcohol Depend"},{"key":"6066_CR16","first-page":"111","volume":"64","author":"GM Allan","year":"2018","unstructured":"Allan GM, Ramji J, Perry D et al (2018) Simplified guideline for prescribing medical cannabinoids in primary care. Can Fam Physician 64:111\u2013120","journal-title":"Can Fam Physician"},{"key":"6066_CR17","first-page":"511","volume":"24","author":"J Husted","year":"1997","unstructured":"Husted J, Gladman D, Farewell V, Long J, Cook R (1997) Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 24:511\u2013517","journal-title":"J Rheumatol"},{"key":"6066_CR18","first-page":"e442","volume":"165","author":"A Devito","year":"2014","unstructured":"Devito A (2014) Interferon \u03b3-induced chemokines in psoriatic arthritis. Clin Ter 165:e442\u2013e446","journal-title":"Clin Ter"},{"key":"6066_CR19","first-page":"53","volume":"2","author":"AA Al-Robaee","year":"2008","unstructured":"Al-Robaee AA, Al-Zolibani AA, Al-Shobili HA, Kazamel A, Settin A (2008) IL-10 Implications in psoriasis. Int J Health Sci 2:53\u201358","journal-title":"Int J Health Sci"},{"key":"6066_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair RP, Duffin KC, Helms C et al (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-\u03baB pathways. Nat Genet 41:199\u2013204","journal-title":"Nat Genet"},{"key":"6066_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/rheumatology\/keq262","volume":"50","author":"DD Gladman","year":"2011","unstructured":"Gladman DD, Chandran V (2011) Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology 50:25\u201331","journal-title":"Rheumatology"},{"key":"6066_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/acr2.11138","volume":"2","author":"M-A Fitzcharles","year":"2020","unstructured":"Fitzcharles M-A, Rampakakis E, Sampalis J et al (2020) Medical cannabis use by rheumatology patients following recreational legalization: a prospective observational study of 1000 patients in Canada. ACR Open Rheumatol 2:286\u2013293","journal-title":"ACR Open Rheumatol"},{"key":"6066_CR23","doi-asserted-by":"crossref","unstructured":"Lake S, Walsh Z, Kerr T, et al. (2019) Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: a longitudinal analysis. PLOS Med 16:e1002967.","DOI":"10.1371\/journal.pmed.1002967"},{"key":"6066_CR24","doi-asserted-by":"crossref","unstructured":"Callaghan RC, Sanches M, Benny C, Stockwell T, Sherk A, Kish SJ (2019) Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity. Drug Alcohol Depend;205:107587.","DOI":"10.1016\/j.drugalcdep.2019.107587"},{"key":"6066_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2011.04.005","volume":"41","author":"DL Goldenberg","year":"2011","unstructured":"Goldenberg DL, Clauw DJ, Fitzcharles M-A (2011) New concepts in pain research and pain management of the rheumatic diseases. Semin Arthritis Rheum 41:319\u2013334","journal-title":"Semin Arthritis Rheum"},{"key":"6066_CR26","unstructured":"Canada H. ARCHIVED \u2013 market data under the Access to Cannabis for Medical Purposes Regulations \u2013 Canada.ca. Available at: https:\/\/www-canada-ca.myaccess.library.utoronto.ca\/en\/ health-canada\/services\/drugs-medication\/cannabis\/licensed-producers\/market-data.html. Accessed June 7, 2019."},{"key":"6066_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/can.2018.0036","volume":"4","author":"DT Eurich","year":"2019","unstructured":"Eurich DT, Hanlon JG, Boisvenue JJ, Meng H, Dyck JRB (2019) A description of the medical cannabis use in Ontario. Canada Cannabis Cannabinoid Res 4:131\u2013135","journal-title":"Canada Cannabis Cannabinoid Res"},{"key":"6066_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1471-2474-15-258","volume":"15","author":"M-A Fitzcharles","year":"2014","unstructured":"Fitzcharles M-A, Ste-Marie PA, Clauw DJ et al (2014) Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints. BMC Musculoskelet Disord 15:258","journal-title":"BMC Musculoskelet Disord"},{"key":"6066_CR29","doi-asserted-by":"crossref","unstructured":"St. Pierre M, Matthews L, Walsh Z (2020) Cannabis education needs assessment among Canadian physicians-in-training. Complement Ther Med;49:102328.","DOI":"10.1016\/j.ctim.2020.102328"},{"key":"6066_CR30","doi-asserted-by":"crossref","unstructured":"Fiz J, Dur\u00e1n M, Capell\u00e0 D, Carbonell J, Farr\u00e9 M (2011) Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. PLOS ONE;6:e18440.","DOI":"10.1371\/journal.pone.0018440"},{"key":"6066_CR31","doi-asserted-by":"crossref","unstructured":"Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky Benjaminov F, Konikoff FM (2013) Cannabis induces a clinical response in patients with Crohn\u2019s disease: a prospective placebo-controlled study. Clin Gastroenterol Hepatol 11:1276\u201380e1.","DOI":"10.1016\/j.cgh.2013.04.034"},{"key":"6066_CR32","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/clpt.1985.226","volume":"38","author":"GM Ellis","year":"1985","unstructured":"Ellis GM, Mann MA, Judson BA, Schramm NT, Tashchian A (1985) Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Ther 38:572\u2013578","journal-title":"Clin Pharmacol Ther"},{"key":"6066_CR33","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1176\/ajp.139.9.1196","volume":"139","author":"CA Dackis","year":"1982","unstructured":"Dackis CA, Pottash AL, Annitto W, Gold MS (1982) Persistence of urinary marijuana levels after supervised abstinence. Am J Psychiatry 139:1196\u20131198","journal-title":"Am J Psychiatry"},{"key":"6066_CR34","doi-asserted-by":"crossref","unstructured":"Ellis RJ, Peterson SN, Li Y, et al. Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood. Neurol - Neuroimmunol Neuroinflammation 2020;7. Available at: https:\/\/nn.neurology.org\/content\/7\/5\/e809. Accessed May 26, 2021.","DOI":"10.1212\/NXI.0000000000000809"},{"key":"6066_CR35","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41423-020-0437-4","volume":"18","author":"K Kotschenreuther","year":"2021","unstructured":"Kotschenreuther K, Waqu\u00e9 I, Yan S et al (2021) Cannabinoids drive Th17 cell differentiation in patients with rheumatic autoimmune diseases. Cell Mol Immunol 18:764\u2013766","journal-title":"Cell Mol Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06066-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:04:44Z","timestamp":1651316684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06066-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6066"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06066-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"assertion":[{"value":"22 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Research Ethics Board of the University Health Network through the IPART Research Program (UHN REB#08\u20130630-AE).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"No patient identifying information is contained in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they do not have any potential conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}